News Olumiant Approved for COVID-19 Treatment in Hospitalized Adults Publish Date May 11, 2022 The approval was based on data from the phase 3 ACTT-2 and COV-BARRIER studies.
News Dapagliflozin Does Not Improve Kidney Outcomes in Hospitalized COVID-19 Cases Publish Date May 10, 2022 Investigators report findings from a secondary analysis of the DARE-19 trial, which compared dapagliflozin with placebo in patients hospitalized with COVID-19.